SHIRIEN COOVER: Open Payments
NPI 1730349358 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,069 in 43 payments from 14 companies in 2025. Trend: 2023 $895 · 2024 $1,185 · 2025 $1,069
Food & beverage: $889Education: $180
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $262 |
| UCB, Inc. | 6 | $148 |
| Novartis Pharmaceuticals Corporation | 4 | $108 |
| E.R. Squibb & Sons, L.L.C. | 5 | $102 |
| ABBVIE INC. | 4 | $98 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
| Regeneron Healthcare Solutions, Inc. | 2 | $62 |
| GENZYME CORPORATION | 1 | $41 |
| Organon LLC | 2 | $39 |
| Amgen Inc. | 2 | $35 |
Products named: TREMFYA, DUPIXENT, Bimzelx, Sotyktu, SKYRIZI, COSENTYX, OTEZLA, HADLIMA.
Industry payments across TX — which companies pay providers there.
